Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Smart Shoes Market $2.11B by 2033
Consumers’ shift towards a healthy lifestyle in the United Kingdom is predicted to boost demand for smart shoes.
Rockville, July 20, 2023 (GLOBE NEWSWIRE) -- As per a new research report by Fact.MR, a provider of market research and competitive intelligence, the Smart Shoes Market stands at US$ 270 million in 2023. Worldwide demand for smart shoes is projected to rise at an exceptionally high CAGR of 22.8% through 2033. Surging sales of smart shoes are attributed to their rapidly growing use in sports and fitness activities.
Nike, in September 2021, launched smart shoes with a theme of Oklahoma Sooners. These shoes feature better body balancing and lightweight capabilities.
The smart shoes sector is expected to grow due to the development of footwear that caters to the needs of older individuals and those focused on maintaining their health. Furthermore, the rising research and development efforts aimed at technological enhancements, such as incorporating sensors with alert capabilities for speed regulation and obstacle detection, are anticipated to drive the demand for smart shoes.
For More Insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=8717
Smart shoes, although resembling regular footwear, have special features that work in conjunction with users' smartphones. They are insole devices equipped with sensors that enable various functionalities such as navigation, receiving vibrations, calculating calorie burn and steps, and more. By connecting smart shoes to their smartphones via Bluetooth, users can access information about their engagement in different physical activities.
Key Takeaways from Market Study
The global smart shoes market is valued at US$ 270 million in 2023.
Worldwide demand for smart shoes is predicted to increase at a CAGR of 22.8% from 2023 to 2033.
The market is set to reach a valuation of US$ 2.11 billion by the end of 2033.
The adults segment is projected to expand at a CAGR of 20% through 2033.
Sales of smart shoes in the United States are forecasted to reach US$ 597 million by 2033-end.
Demand for step-counting shoes is set to accelerate at 22.9% CAGR through 2033.
The Indian market is forecasted to expand at a CAGR of 28.3% and reach US$ 202 million by 2033.
The smart shoes market in China is estimated to reach US$ 697 million by the end of 2033.
NEWS OUT!
https://www.otcmarkets.com/stock/MLRT/news/story?e&id=2587353
MetAlert Increases Value of its IP Portfolio by Receiving Notice of Allowance from EPO for New GPS SmartSole Patent
LOS ANGELES, CALIFORNIA, July 26, 2023 (GLOBE NEWSWIRE) -- MetAlert, Inc. (OTC: MLRT), a pioneer in location sensitive health monitoring devices and wearable technology products announced it has received a notice of allowance for a new patent by the European Patent Office (EPO). This will be the company’s first European utility patent in the GPS SmartSole family and will cover various ways to design, protect and manufacture a GPS, Cellular, Bluetooth and Wi-Fi monitoring electronic device embedded inside an insole including the inductive charging unit. This is the fifth patent granted to Metalert around tracking and monitoring devices within footwear with particular protection on the insole format.
“We have been working on this European patent for several years and we were very pleased to hear the news about the patent allowance. The timing could not have been better as we continue to roll out new generation GPS SmartSole products across Europe and North America. This new patent will provide us additional intellectual property protection in the major Western markets as well as key markets in Japan, S Korea, Australia, and New Zealand.” said Andrew Duncan Metalert Director.
“The patent has a large number of claims, with the opportunity to file additional divisional patents in the future and offers us protection against competition as well as possibly opening up new, oftentimes lucrative, licensing and partnership opportunities. While our ongoing investment in IP demonstrates MetAlert’s commitment to enhance our competitive barriers in the market, it also helps strengthen our overall value in the wearable tech industry,” stated Patrick Bertagna MetAlert CEO.
To find out more how you can buy or become an authorized reseller contact info@metalert.com business development.
Social Media:
FB: https://www.facebook.com/metalertinc
IG: https://www.instagram.com/metalert/?hl=en
Twitter: https://twitter.com/metalertinc
Linked In: https://www.linkedin.com/company/metalertinc/
YouTube: https://www.youtube.com/channel/UCUlYP1WQoLdKkDzwhGkx40Q
General information, investor relations, wholesale licensing, consumer purchase:
Tel: 213.489.3019 Email: info@metalert.com or ir@metalert.com website www.metalert.com
MetAlert
United Kingdom, London
Nelson Skip Riddle
Tel: +44 7785 364100
Email: nsriddle@metalert.com
About MetAlert, Inc.:
MetAlert (OTC: MLRT) and its subsidiaries are engaged in designing, developing, manufacturing, distributing, selling, and licensing products, services, and intellectual property in the GPS/BLE wearable technology, personal location, wandering assistive technology, and health data collection and monitoring. With over 20 years of experience and an extensive patent portfolio, MetAlert is a leading solution provider for consumers/patients afflicted with Alzheimer, dementia, and autism. This market represents approximately 2.9% of the world’s population. The company offers global end-to-end hardware, software, and connectivity solutions, in addition to developing two-way tracking technologies, which seamlessly integrate with consumer products, enterprise and government agency applications. Utilizing the latest in miniaturized, low power consumption GPS, Cellular, RF, NFC, and BLE technologies, enabling caregivers to track and monitor patients in real time. Known for its game-changing and award-winning patented GPS SmartSole® -- think Dr. Scholl’s meets LoJack, the world’s first invisible wearable technology tracking device created for those at risk of wandering due to Alzheimer’s, dementia, autism, and traumatic brain injury. MetAlert’s subscription-based business model is built around technology innovation with intellectual property protection. The company has international distributors servicing customers across the globe with subscribers in over 40 countries and is a U.S. Military Government contractor. Other customers include public health authorities, municipalities, emergency and law enforcement, private schools, assisted living facilities, NGOs, small business enterprises, senior care homes, and consumers. www.MetAlert.com
Forward-Looking Statements
This news release contains forward-looking statements. The terms and phrases “expects,” “would,” “will,” “believes,” and similar terms and phrases are intended to identify these forward-looking statements. Forward-looking statements are based on estimates and assumptions made by MetAlert considering its experience and perception of current conditions and expected future developments, as well as other factors that MetAlert believes are appropriate in the circumstances. Many factors could cause MetAlert’s actual results, performance, or achievements to differ materially from those expressed or implied by the forward-looking statements. Certain risk factors that may cause actual results to differ are outlined in MetAlert’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (which may be obtained on the SEC Website). These factors should be considered carefully, and readers should not rely on MetAlert’s forward-looking statements. MetAlert has no intention and undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required.
MLRT (.11) AI deal with Walmart is rocket fuel
Telehealth deal with AI virtual assistant now connects MLRT to Walmart urgent care
This isn't going to remain at .11 much longer!
https://finance.yahoo.com/news/metalert-introduces-ai-technology-virtual-121100307.html
MLRT (.11) AI deal with Walmart is rocket fuel
Telehealth deal with AI virtual assistant now connects MLRT to Walmart urgent care
This isn't going to remain at .11 much longer!
https://finance.yahoo.com/news/metalert-introduces-ai-technology-virtual-121100307.html
MLRT --> AI healthcare, Walmart telehealth deal
Market cap: $2M
NO TOXIC DEBT (no dilution)
MLRT --> AI healthcare, Walmart telehealth deal
Market cap: $2M
NO TOXIC DEBT (no dilution)
No toxic notes for diltution
Market cap only $2M, no toxic debt
Value is super cheap here at only around $2 million.
- SmartSole's for Alzheimer's
- Telehealth with Walmart
- AI healthcare analytics
No toxic notes for dilution
When compared to some other stocks out there no reason this can't be trading at $10M market cap, or like .50+
https://www.otcmarkets.com/stock/MLRT/security
This moving to Expert Market
...and yesterday is showed some trading platforms were banning buy orders which means their 15c-211 may already have been pulled.
Caution
MLRT (.12) --> AI + Healthcare + IBM
Next Realm AI, an #IBM Business Partner, will help advise and collaborate with MetAlert $MLRT on developing AI solutions for the healthcare market.#healthcare #analytics #ArtificialIntelligence #stockstowatch #nextrealmaihttps://t.co/71O05Vblvr
— AI Venturetech (@aiventuretech) July 17, 2023
MLRT (.12) AI + Healthcare + IBM
Next Realm AI, an #IBM Business Partner, will help advise and collaborate with MetAlert $MLRT on developing AI solutions for the healthcare market.#healthcare #analytics #ArtificialIntelligence #stockstowatch #nextrealmaihttps://t.co/71O05Vblvr
— AI Venturetech (@aiventuretech) July 17, 2023
AI healthcare solutions with IBM
This would turbo charge this stock up for hot sector now
Next Realm AI, an #IBM Business Partner, will help advise and collaborate with MetAlert $MLRT on developing AI solutions for the healthcare market.#healthcare #analytics #ArtificialIntelligence #stockstowatch #nextrealmaihttps://t.co/71O05Vblvr
— AI Venturetech (@aiventuretech) July 17, 2023
$MLRT - AI health assistant + Walmart deal (see chart)
$MLRT enters #AI virtual health assistant market with #telehealth deal connected to #Walmart #healthcare #artificialintelligence #generativeAI https://t.co/54hIbYdK6p
— Ludlow Research (@LudlowResearch) July 13, 2023
$MLRT .13 --> IBM and AI + Walmart telehealth
With our established connections at #IBM I would like explore how to leverage @IBMData for Metalert $MLRT and generative AI solutions for healthcare.
— Tom Bustamante (@techwizardtom) July 12, 2023
+ Follow me for updates pic.twitter.com/od9U5MSDqG
$MLRT .13 --> IBM and AI + Walmart telehealth
With our established connections at #IBM I would like explore how to leverage @IBMData for Metalert $MLRT and generative AI solutions for healthcare.
— Tom Bustamante (@techwizardtom) July 12, 2023
+ Follow me for updates pic.twitter.com/od9U5MSDqG
10Q showed lot shares converting .20
I'd wait for pullback into low to mid .20s to buy those shares coming to market.
$MLRT Gets Major Foothold in Healthcare with Walmart Deal
Here are 3 reasons why investors should buy $MLRT stock on this news:
Walmart is a major player in the healthcare industry. This deal gives $MLRT access to Walmart's vast network of healthcare providers, which is a huge opportunity for growth.
The virtual AI healthcare assistant is a game-changer. This new technology will make it easier for patients to access healthcare, and it's sure to be a hit with consumers.
The stock is still undervalued. $MLRT is trading at a fraction of its potential, and this deal is sure to send the stock price higher.
Investors who are looking for a growth stock in the healthcare industry should definitely take a look at $MLRT. This is a company with a bright future, and this deal is just the beginning.
Get in on the ground floor before it's too late!
Voice Technology in Health Care
HandsFree Health is the creator of WellBe®, the premier voice-enabled virtual health assistant platform. With more than 150 years of combined experience in health care, our founding team sought to create a better way for people to manage their health. Our founders knew all too well the challenges that the current health care system presents for all types of people and businesses, including Caretakers, Seniors, Employers, Senior Communities, and Health Plans.
The solution : HandsFree Health—a company swiftly becoming the benchmark for voice technology in health care and medical alert companies.
https://handsfreehealth.com/
Healthcare AI + Walmart...
This could catch fire here once it breaks above .15
Ready to run!
MLRT now part of Walmart healthcare system
This telehealth partnership opens them up to all customers who use Walmart. I see more and more big brand stores moving into healthcare services to compete with likes of Walgreen's and CVS, and Walmart has a huge customer user base.
.15 key breakout trigger
.15 up
This train is leaving station, and still hasn't hit radars yet
Bid moving up, her we go...ready to pop!
Breaking early April high and could see this quickly run to .20+ here
Walmart urgent healthcare services
MLRT (.11) running! Walmart telehealth + AI
AI Venturetech initiates alert on MetAlert $MLRT ($0.09) on use of #AI smart health assistant for their new #telehealth platform.
— AI Venturetech (@aiventuretech) June 29, 2023
✅ AI tech in #healthcare
Share structurehttps://t.co/Ei1lAactih pic.twitter.com/lWO6SMJ6G4
MLRT now part of Walmart healthcare services
The deal with HandsFree Heath now places MLRT with Walmart's healthcare services.....this is big for many customers on Wallmart system that may use telehealth for Walmart's urgent care.
AI Venturetech initiates alert on MetAlert $MLRT ($0.09) on use of #AI smart health assistant for their new #telehealth platform.
— AI Venturetech (@aiventuretech) June 29, 2023
✅ AI tech in #healthcare
Share structurehttps://t.co/Ei1lAactih pic.twitter.com/lWO6SMJ6G4
Deal with Walmart!
WellBe has deal with Walmart, and MLRT telehealth may become part of Walmart's healthcare ecosystem - huge!
https://www.prnewswire.com/news-releases/handsfree-health-expands-its-home-healthcare-products-at-walmart-301417308.html
MLRT (.10) AI smart health assistant
AI Venturetech initiates alert on MetAlert $MLRT ($0.09) on use of #AI smart health assistant for their new #telehealth platform.
— AI Venturetech (@aiventuretech) June 29, 2023
✅ AI tech in #healthcare
Share structurehttps://t.co/Ei1lAactih pic.twitter.com/lWO6SMJ6G4
MLRT (.10) AI smart health assistant
AI Venturetech initiates alert on MetAlert $MLRT ($0.09) on use of #AI smart health assistant for their new #telehealth platform.
— AI Venturetech (@aiventuretech) June 29, 2023
✅ AI tech in #healthcare
Share structurehttps://t.co/Ei1lAactih pic.twitter.com/lWO6SMJ6G4
IFAN moving up .0008
Merger rumor swirling here
https://www.cnbc.com/quotes/IFAN